UNSPSC 51282504: Cefaloglycin or cephaloglycin

This classification denotes a cephalosporin antibiotic with the molecular structure C18H19N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, HD2D469W6U chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6r-(6.alpha.,7.beta.(r*))) but generally known as cefaloglycin, which bears US NIH Compound Identifier 19150. European Medicines Agency schedules Cefaloglycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06166MIG.

The term CEFALOGLYCIN is an International Non-Proprietary Name or INN. Cefaloglycin or cephaloglycin bears US NLM identifiers UMLS ID C0007721 and NCI Concept Code C65307. SMILES: S1C2N(C(=O)C2NC(=O)C(N)C2CCCCC2)C(=C(C1)COC(=O)C)C(=O)O.

UNSPSC 51282504 Cefaloglycin or cephaloglycin is a Commodity code, but the recent state and local solicitations tagged under it do not reflect pharmaceutical manufacturing or supply of cephalosporin antibiotics; instead, they document procurement of naloxone kits, safe drug deactivation systems, medical and first aid supplies for emergency responders, and generic multi-source pharmaceuticals through cooperative purchasing arrangements. The code shows a mismatch between its nominal scope and what state and local governments are actually buying under this classification.

The four recent opportunities posted between January and July 2026 span different issuing bodies and procurement mechanisms. Seminole County, Florida issued IFB 60459723LAS for naloxone and drug deactivation systems (quarterly deliveries to the county community health building); the City of Tampa released IFB 26-P-00145 for medical and first aid supplies for the Tampa Fire Department Rescue Division, a $700,000 sheltered-market procurement reserved for certified Small Local Business Enterprises with a 5 percent bid discount; the Texas Health and Human Services Commission posted RFI HHS0017013 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program; and the Minnesota Multistate Cooperative Purchasing Alliance (administered by Minnesota Department of Administration) issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, including Oregon, with proposals due March 26, 2026. Activity appears concentrated in Florida and Texas, with participation from Minnesota's multistate cooperative. The code shows little relevant recent activity aligned to cephalosporin antibiotic procurement and may reflect data-entry or classification error by soliciting agencies.